Literature DB >> 13903962

Agranulocytosis caused by methyl dopa (Aldomet).

G P HALLWRIGHT.   

Abstract

Entities:  

Keywords:  AGRANULOCYTOSIS/etiology; DOPA/related compounds

Mesh:

Substances:

Year:  1961        PMID: 13903962

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


× No keyword cloud information.
  12 in total

1.  PARKINSONISM ASSOCIATED WITH ALPHA-METHYLDOPA THERAPY.

Authors:  M J PEASTON
Journal:  Br Med J       Date:  1964-07-18

2.  Treatment of severe hypertension with methyldopa.

Authors:  M HAMILTON; H KOPELMAN
Journal:  Br Med J       Date:  1963-01-19

3.  Methyldopa.

Authors: 
Journal:  Br Med J       Date:  1962-06-16

4.  Methyldopa in the Treatment of Hypertension.

Authors:  P Lauwers; M Verstraete; J V Joossens
Journal:  Br Med J       Date:  1963-02-02

5.  Methyldopa in Hypertension.

Authors: 
Journal:  Br Med J       Date:  1963-02-02

6.  Hyperpyrexia During Treatment with Methyldopa.

Authors:  V M Montegriffo
Journal:  Br Med J       Date:  1963-07-06

7.  Alpha-Methyl DOPA and Hypertension.

Authors: 
Journal:  Can Med Assoc J       Date:  1962-08-04       Impact factor: 8.262

8.  Methyldopa-induced thrombocytopenia.

Authors:  A Ten Pas; N K de Leeuw; C H Stacey
Journal:  Can Med Assoc J       Date:  1966-08-13       Impact factor: 8.262

9.  Haemolysis and agranulocytosis complicating treatment with methyldopa.

Authors:  K G Clark
Journal:  Br Med J       Date:  1967-10-14

10.  Methyldopa and associated thrombocytopenia.

Authors:  S M Manohitharajah; W J Jenkins; P D Roberts; R C Clarke
Journal:  Br Med J       Date:  1971-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.